A Guide to the Evidence | |
Rating the Quality of Evidence and Making Recommendations: A Guide to the Spectrum of Clinical Research | |
An Overview of Systematic Reviews | |
Interpreting Results in Clinical Research: Overview of measures of effect, measures of precision, and measures of diagnostic accuracy for clinicians and researchers | |
Finding the Evidence in Hematology | |
Applying EBM in Clinical Practice | |
Using Evidence to Guide the Diagnosis of Disease | |
Hemostasis and Thrombosis | |
Diagnosis of Deep Vein Thrombosis | |
The Diagnosis of Acute Pulmonary Embolism | |
Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism | |
Long-Term Anticoagulation in Venous Thromboembolism | |
Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism | |
Inferior Vena Cava Interruption | |
Management of Venous Thromboembolism in Pregnancy | |
Pediatric Thrombosis | |
Bridging Anticoagulation in PatientsWho Require Temporary Interruption ofWarfarin for Surgery | |
Evidence-based Approach to the Diagnosis and Management of Thrombotic Thrombocytopenic Purpura | |
Diagnosis and Management of Disseminated Intravascular Coagulation | |
Diagnosis and Management of Hereditary Bleeding Disorders: Including Congenital/Acquired Platelet Function Disorders | |
Diagnosis and Management of Acquired Bleeding Disorders: Vitamin K Antagonists | |
Diagnosis and Management of Heparin-Induced Thrombocytopenia | |
Management of Antiphospholipid Antibody Syndrome | |
Benign Hematologic Disorders | |
Clinical Questions in Iron Overload | |
Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and Pure Red Cell Aplasia | |
Acquired Anemias: Iron Deficiency, Cobalamin Deficiency, and Autoimmune Hemolytic Anemia | |
Immune Thrombocytopenic Purpura | |
Neutropenia | |
Hypereosinophilia: Primary and Secondary | |
Porphyrias | |
Membrane and Enzyme Abnormalities of the Erythrocyte | |
Sickle Cell Disease | |
Evidence-based Treatment of Thalassemia Major | |
Malignant Hematologic Disorders | |
Acute Lymphoblastic Leukemia in Adults | |
Acute Myeloid Leukemia in Adults: Remission: Induction Therapy | |
Acute Myeloid Leukemia in Adults: Postremission Therapy | |
Current Areas of Controversy in the Treatment of Patients With Newly Diagnosed Acute Promyelocytic Leukemia | |
Chronic Lymphocytic Leukemia | |
Chronic Myeloid Leukemia | |
Selected Management of Patients with Myelodysplastic Syndromes | |
Evidence-based Treatment of Burkitt Lymphoma in Adults | |
Primary Central Nervous System Lymphoma | |
Diffuse Large B-cell Lymphoma | |
Follicular Lymphoma | |
Lymphoblastic Lymphoma | |
Mantle Cell Lymphoma | |
Management of Patients with Peripheral T-cell Lymphoma | |
Selected Management Issues of Patients with Hodgkin Lymphoma | |
Lymphocyte Predominant Hodgkin Lymphoma | |
Management of Patients with Essential Thrombocythemia | |
Management of Patients with Polycythemia Vera | |
Evidence-based Review of Therapies in Multiple Myeloma | |
Management ofWaldenstrom's Macroglobulinemia | |
The Role of Hematopoietic Growth Factors in Managing Patients with Hematologic Malignancies | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.